iiinova — where your digital self keeps evolving

Stephen Chin

@schinau.bsky.social

#radonc in mainly GU, thoracic, lower GI & gyn ca. interests in palliative onc, #brachy, SABR, MR in RT www.linkedin.com/in/stephenchin001

Posts Replies Media

Reposted by Stephen Chin

Ananya Choudhury @achoud72.bsky.social · 13/02/2025

Our review on the promise of #radiotherapy in #NMIBC #Openaccess #WhereisHoskin @mcrcnews.bsky.social @oncoalert.bsky.social @southamptonctu.bsky.social #TRAINTrial www.mdpi.com/2072-6694/17...

mdpi.com

The Promise of Radiotherapy in High-Risk Non-Muscle Invasive Bladder Cancer

Global shortages, toxicities, and high levels of incomplete treatment with Bacillus Calmette Guerin (BCG) for non-muscle invasive bladder cancer has resulted in increasing interest in alternative trea...

0114

Reposted by Stephen Chin

Matthias Guckenberger @mguckenberger.bsky.social · 02/01/2025

Aiming to refine your #radonc in 2025 ! Offer RT for low-volume metastatic PC, only ? What benefit of RT is to be communicated to pts & colleagues ? How about SBRT or surgery ? Virtual Grand Rounds in Radiation Oncology Jan 8th / 17:00 - 17:30 CET Dr Alberto Bossi 👇 www.usz.ch/veranstaltun...

0122

Reposted by Stephen Chin

The OncoAlert Network 🚨 @oncoalert.bsky.social · 28/11/2024

Day Two of #BLADDR24 Dr Vérane Achard BCa management in 2025 View of the radiation oncologist Radiotherapy is no longer just an alternative to surgery but a key component @drnataliagandur.bsky.social @barbaramelao.bsky.social @yukselurun.bsky.social @achoud72.bsky.social

084

Reposted by Stephen Chin

Ananya Choudhury @achoud72.bsky.social · 27/11/2024

#WhereisHoskin appears on #BlueSky How to further personalise #radiotherapy ➡️ Bladder only unless N+ ➡️ Give NAC if appropriate ➡️ Use a radiosensitiser, any radiosensitiser ➡️ There are compelling biomarkers, but need prospective qualification #BLADDR24 @oncoalert.bsky.social

1125